XML 139 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Income - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Net sales $ 1,022.8 $ 1,041.3 $ 982.1
Cost of products sold 732.8 762.8 698.7
Gross profit 290.0 278.5 283.4
Selling expense 33.7 35.7 33.3
Research expense 13.5 15.2 17.8
General expense 105.1 90.9 95.9
Total nonmanufacturing expenses 152.3 141.8 147.0
Restructuring and impairment expense 3.7 1.7 8.1
Operating profit 134.0 135.0 128.3
Interest expense 36.1 28.2 26.9
Other (expense) income, net (1.0) 10.0 0.1
Income from continuing operations before income taxes and income from equity affiliates 96.9 116.8 101.5
Provision for income taxes 15.2 10.7 69.6
Income (Loss) from equity affiliates, net of income taxes 4.1 (11.3) 2.5
Income from continuing operations 85.8 94.8 34.4
(Loss) gain from discontinued operations 0.0 (0.3) 0.1
Net income $ 85.8 $ 94.5 $ 34.5
Net income (loss) per share - basic:      
Income per share from continuing operations (in dollars per share) $ 2.78 $ 3.08 $ 1.12
Loss per share from discontinued operations (in dollars per share) 0 (0.01) 0
Net income per share - basic (in dollars per share) 2.78 3.07 1.12
Net income (loss) per share – diluted:      
Income per share from continuing operations (in dollars per share) 2.76 3.07 1.12
Loss per share from discontinued operations (in dollars per share) 0 (0.01) 0
Net income per share - diluted (in dollars per share) $ 2.76 $ 3.06 $ 1.12
Weighted average shares outstanding:      
Basic (in shares) 30,652,200 30,551,300 30,407,100
Diluted (in shares) 30,838,300 30,692,900 30,549,300